Cargando…
Myelodysplastic/ Myeloproliferative Neoplasms-Unclassifiable (MDS/MPN-U) with Isolated Isochromosome 17q Represents a Distinct Clinico-Biologic Subset: A Multi-institutional Collaborative Study from the Bone Marrow Pathology Group
Classification of myeloid neoplasms with isolated i(17q) [17p deletion with inherent monoallelic TP53 loss plus 17q duplication] is controversial. Most cases fall within the WHO unclassifiable myelodysplastic/myeloproliferative neoplasms (MDS/MPN-U) category. The uniformly dismal outcomes warrant be...
Autores principales: | Kanagal-Shamanna, Rashmi, Orazi, Attilio, Hasserjian, Robert P., Arber, Daniel A., Reichard, Kaaren, Hsi, Eric D., Bagg, Adam, Rogers, Heesun Joyce, Geyer, Julia, Darbaniyan, Faezeh, Do, Kim-Anh, Devins, Kyle M., Pozdnyakova, Olga, George, Tracy I., Cin, Paola Dal, Greipp, Patricia T., Routbort, Mark J., Patel, Keyur, Garcia-Manero, Guillermo, Verstovsek, Srdan, Medeiros, L. Jeffrey, Wang, Sa A., Bueso-Ramos, Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967812/ https://www.ncbi.nlm.nih.gov/pubmed/34775472 http://dx.doi.org/10.1038/s41379-021-00961-0 |
Ejemplares similares
-
Myelodysplastic/Myeloproliferative Neoplasms, Unclassifiable (MDS/MPN, U): Natural history and clinical outcome by treatment strategy
por: DiNardo, CD, et al.
Publicado: (2014) -
Myeloid neoplasms with isolated isochromosome 17q demonstrate a high frequency of mutations in SETBP1, SRSF2, ASXL1 and NRAS
por: Kanagal-Shamanna, Rashmi, et al.
Publicado: (2016) -
Targeting cistrome and dysregulated transcriptome of post-MPN sAML
por: Verstovsek, Srdan, et al.
Publicado: (2017) -
Bone marrow morphology is a strong discriminator between chronic eosinophilic leukemia, not otherwise specified and reactive idiopathic hypereosinophilic syndrome
por: Wang, Sa A., et al.
Publicado: (2017) -
Pure (acute) erythroid leukemia: morphology, immunophenotype, cytogenetics, mutations, treatment details, and survival data among 41 Mayo Clinic cases
por: Reichard, Kaaren K., et al.
Publicado: (2022)